Sign in
Not yet taking people in United StatesNo phase

Contingency Management to Promote Smoking Cessation Study

Key facts

Who runs it
University of Kansas Medical Center
Where
Kansas City, United StatesSee the site
Trial code
Status
Not yet recruiting
People taking part
40 people, planned
Started
6 Nov 2026
Expected to end
30 May 2027
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Health Rewards
  • Control
Record updated
27 October 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 16 criteriaShow less

Who can take part

  • Smoked in the past 30 days
  • Smoke at least 1 cigarette per day when they smoke
  • ≥ 18 years old
  • Kansas resident
  • Speak/read English
  • Access to a mobile phone
  • Mobile phone receives text messages
  • No varenicline contraindications (no acute renal impairment)
  • Have no significant co-morbidity (i.e., life-threatening illness, communication barriers or altered mental status)
  • Cognitively able to participate
  • Physically able to participate
  • Not pregnant/breastfeeding

Who cannot take part

  • Patient on smoking cessation medication within 2 weeks of admission date
  • Medically ineligible for varenicline
  • Patient already talked to quitline in the past 2 weeks
  • Patients participating in other quit smoking program or research study

Where in United States

  • University of Kansas Medical CenterKansas City, United StatesContact: Erica CruvinelNot yet recruiting

About the trial

What the trial wants to find out

Adherence to medication and counseling are strong predictors of smoking cessation success. To provide these two components of care, healthcare providers typically provide people who smoke with prescriptions for cessation medications, and refer them to state-sponsored tobacco quitlines. However, most people who smoke that are referred to quitlines never actually enroll, and those who do enroll participate in very few sessions. Similarly, most people who smoke that receive prescriptions for cessation medications rarely fill or use them, even when they have no co-pay or pre-authorization requirements. To address this problem, the investigators will recruit 40 patients for a pilot 2-arm effectiveness trial. Investigators will recruit patients from the University of Kansas Medical Center. Participants will then be randomized either to control or Health Reward. All participants will receive 12 weeks of varenicline and referrals to their state tobacco quitline (Control condition). In Health rewards arm, participants will additionally receive CM for medication (MedCM) and for counseling (CounsCM). The use of medication will be tracked using an electronic pill dispenser (Wisepill). All participants will be contacted for follow up 3, 6 and 12 weeks after starting the treatment. Feasibility data will include recruitment and retention rates. Preliminary effectiveness outcomes will include treatment engagement and cessation rates.

The 2 groups in the trial

  • CounsCM+MedCMTreatment being tested

    Mobile Contingency management for counseling attendance (CounsCM) and medication intake (MedCM)

    Treatment: Health Rewards

  • ControlExisting treatment, for comparison

    12 weeks of varenicline and referral to state quitline

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Contingency Management to Promote Smoking Cessation: A Pilot Randomized Clinical Trial
Record updated
27 October 2026